[Translation] A randomized, double-blind, dose-parallel, multicenter phase IIa clinical trial on the efficacy and safety of Renzhu Changle Granules in the treatment of diarrhea-predominant irritable bowel syndrome (liver stagnation and spleen deficiency syndrome)
对仁术肠乐颗粒治疗腹泻型肠易激综合征(肝郁脾虚证)进行剂量探索,同时初步评价其有效性和安全性,为后续临床试验提供数据支持。
[Translation] To explore the dosage of Renzhu Changle Granules in the treatment of diarrhea-type irritable bowel syndrome (liver stagnation and spleen deficiency syndrome), and to evaluate its efficacy and safety preliminarily, so as to provide data support for subsequent clinical trials.